Fontem US Fails in Bid to Halt Myblu Ban

Jul.26.2022
Fontem US Fails in Bid to Halt Myblu Ban
Fontem US's request for an emergency motion to suspend its marketing injunction was rejected by the US Court of Appeals.

The US Court of Appeals for the District of Columbia has rejected Fontem US's emergency motion to lift the marketing denial order (MDO), as reported by vaporvoice. The court refused to grant the stay of the order due to Fontem's delay in filing the motion.


Fontem Ventures, a subsidiary of Imperial Brands PLC and the parent company of Fontem US, which owns the global e-cigarette brand blu, has been ordered to remove its Myblu product from store shelves. This ruling means that Fontem is legally required to comply with the marketing denial order (MDO) and if they choose to appeal, they will have to follow legal procedures.


The court stated: "Fontem has demonstrated that the Marketing Denial Order (MDO) is causing harm to its business, but they waited over two months after the MDO was issued to seek a temporary solution. The court found Fontem's argument for business harm to be insufficient.


The court stated that Fontem has not provided a strong indication that it may successfully appeal the marketing denial order (MDO) issued in the United States. The U.S. FDA identified several reasons for issuing the MDO and provided Fontem with fair notice.


The court stated that Fontem US, LLC did not meet the strict requirements for filing a motion to stay the injunction prior to court review.


The FDA has issued a Marketing Denial Order (MDO) against several myblu brand products manufactured by Fontem US. This includes tobacco and electronic cigarette products that have received negative action for their Pre-Market Tobacco Product Application (PMTA) submission prior to market release. These products, including those restrained by MDO, are prohibited from being sold, distributed, or marketed in the United States.


In a press release, the FDA stated that on April 8th, they issued a Marketing Denial Order (MDO) to Fontem US, LLC for several myblu electronic nicotine delivery system (ENDS) products, as it had been determined that there was insufficient evidence to prove that selling these products would be conducive to protecting public health.


Sorry, I am an AI language model and need the original text to translate it. Please provide the text for me to assist you.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

QISI’s Dongguan Factory Posts Recruitment Notice for Production Positions
QISI’s Dongguan Factory Posts Recruitment Notice for Production Positions
QISI’s Dongguan factory has posted new production job openings, following earlier reports of a shutdown at its Zhuhai site.
Oct.15
U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million
U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million
U.S. Customs and Border Protection (CBP) seized approximately 165,000 illicit vaping products—including 90,000 e-cigarette devices and 75,000 refill cartridges—valued at over $1.47 million (MSRP). Following a joint assessment with the U.S. Food and Drug Administration (FDA), the products were deemed “adulterated and misbranded” for lacking required premarket authorization and were seized in accordance with the Federal Food, Drug, and Cosmetic Act (FD&C Act). The shipments, which featured multipl
Sep.30 by 2FIRSTS.ai
Lithuanian Schools Install Vape Detectors as Teen Vaping Surges
Lithuanian Schools Install Vape Detectors as Teen Vaping Surges
Over 30 Lithuanian schools have installed smart vape detectors to curb rising teen e-cigarette use. WHO data show Lithuania ranks worst among 44 countries, with 60% of 15-year-olds having tried vaping. The system alerts staff to smoke and noise changes, helping schools reduce on-campus vaping cases.
Oct.27 by 2FIRSTS.ai
Chonburi Police Raid Major E-Cigarette and Vape Liquid Warehouse Worth Over US$920,000
Chonburi Police Raid Major E-Cigarette and Vape Liquid Warehouse Worth Over US$920,000
Thailand Chonburi provincial police, in coordination with multiple agencies, raided a large-scale warehouse in downtown Chonburi used for producing and distributing e-cigarettes and vape liquids. Two Chinese nationals were arrested, and more than 40 categories of contraband—including vapes, e-liquids, and production equipment—were seized, with an estimated total value exceeding US$920,000 (about 30 million Thai baht).
Nov.17 by 2FIRSTS.ai
NSW Landlords Could Face Jail or $165,000 Fine for Allowing Illegal Vape and Tobacco Sales
NSW Landlords Could Face Jail or $165,000 Fine for Allowing Illegal Vape and Tobacco Sales
According to The Guardian, landlords in New South Wales who knowingly allow tenants to sell illicit tobacco or illegal vapes could face fines of up to AUD 165,000, a year in prison, or both. The new offences are part of the state government’s broader crackdown on Australia’s growing black market for cigarettes and vaping products.
Nov.12 by 2FIRSTS.ai
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
In an interview with CNN’s Chasing Life, U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary warned that new health risks — from emerging opioids such as 7-OH to unregulated vaping products — are slipping through regulatory cracks. His remarks reveal the FDA’s growing challenge to balance harm reduction for adult smokers with youth protection and cross-border enforcement.
Oct.10